Literature DB >> 15989448

Evaluation of superficial bladder transitional-cell carcinoma by optical coherence tomography.

Michael J Manyak1, Natalia D Gladkova, John H Makari, Arnold M Schwartz, Elena V Zagaynova, Ladan Zolfaghari, Jason M Zara, Rashid Iksanov, Felix I Feldchtein.   

Abstract

BACKGROUND AND
PURPOSE: Optical coherence tomography (OCT) is a new modality that allows noninvasive examination of the internal structure of biological tissue in vivo with a spatial resolution of 10 to 15 microm. This study evaluated the clinical application of OCT to determine epithelial and subepithelial anatomic structure and invasiveness of bladder epithelial lesions.
MATERIALS AND METHODS: The OCT examination was performed with a 980-nm 10 mW superluminescent diode using a 2.7-mm-diameter optical fiber positioned cystoscopically. A total of 261 scans of 1.5 seconds' duration, which generated 200 x 200-pixel images, were performed on 87 areas in 24 patients at high risk of having transitional-cell carcinoma (TCC). Lesions, visually suspect, and normal areas were photographed, scanned, and biopsied. The scans were evaluated independently before comparison with histopathology findings.
RESULTS: Of the 87 areas, 29 of 36 visually suspect areas and 35 of 35 normal areas, were correctly diagnosed with OCT. Of the 16 areas with papillary TCC, all 16 were diagnosed correctly as tumor, and 9 of 10 were diagnosed correctly as invasive, including 6 with lamina propria invasion only. Papillary and flat tumors, carcinoma in situ, inflammation, chronic cystitis, and von Brunn's nests were scanned. Overall, OCT had a sensitivity of 100%, overall specificity of 89%, positive predictive value of 75%, and negative predictive value of 100%. The accuracy was 92%. The positive predictive value for invasion was 90%.
CONCLUSION: Optical coherence tomography is a simple, portable, promising modality for evaluation of bladder lesions and depth of tumor penetration. Further refinement of this technology may lead to the development of an optical surrogate for biopsy.

Entities:  

Mesh:

Year:  2005        PMID: 15989448     DOI: 10.1089/end.2005.19.570

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  24 in total

Review 1.  [Diagnostic procedure for bladder cancer. Standards and current developments].

Authors:  A Karl; S Tritschler; D Zaak; D Tilki; C Stief; M Burger
Journal:  Urologe A       Date:  2010-10       Impact factor: 0.639

Review 2.  Fiberoptic imaging for urologic surgery.

Authors:  Jeremy B Tuttle; William D Steers
Journal:  Curr Urol Rep       Date:  2009-01       Impact factor: 3.092

3.  Optical coherence tomography: a novel modality for scrotal imaging.

Authors:  Cole Davis; Wayne Kuang
Journal:  Can Urol Assoc J       Date:  2009-08       Impact factor: 1.862

Review 4.  Enhanced Endoscopy in Bladder Cancer.

Authors:  Shane Pearce; Siamak Daneshmand
Journal:  Curr Urol Rep       Date:  2018-08-17       Impact factor: 3.092

5.  Three-dimensional, distendable bladder phantom for optical coherence tomography and white light cystoscopy.

Authors:  Kristen L Lurie; Gennifer T Smith; Saara A Khan; Joseph C Liao; Audrey K Ellerbee
Journal:  J Biomed Opt       Date:  2014-03       Impact factor: 3.170

6.  [Non-muscle invasive transitional cell carcinoma of the bladder. New developments in diagnostics and therapy].

Authors:  M Sommerauer; D Jocham; J M Laturnus
Journal:  Urologe A       Date:  2012-06       Impact factor: 0.639

Review 7.  Hexaminolevulinate hydrochloride in the detection of nonmuscle invasive cancer of the bladder.

Authors:  Savino M Di Stasi; Francesco De Carlo; Vincenzo Pagliarulo; Francesco Masedu; Cristian Verri; Francesco Celestino; Claus Riedl
Journal:  Ther Adv Urol       Date:  2015-12

Review 8.  Advances in imaging technologies in the evaluation of high-grade bladder cancer.

Authors:  Dimitar V Zlatev; Emanuela Altobelli; Joseph C Liao
Journal:  Urol Clin North Am       Date:  2015-02-28       Impact factor: 2.241

9.  Application of new technology in bladder cancer diagnosis and treatment.

Authors:  Alvin C Goh; Seth P Lerner
Journal:  World J Urol       Date:  2009-02-22       Impact factor: 4.226

Review 10.  [Supplementary optical techniques for the detection of nonmuscle invasive bladder cancer].

Authors:  S Aeishen; Y Dawood; S Papadoukakis; M Horstmann
Journal:  Urologe A       Date:  2018-02       Impact factor: 0.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.